Literature DB >> 32042704

Imatinib-induced Gynecomastia.

Pragya Gupta1, Kripa Elizabeth Cherian1, Nitin Kapoor1, Nambiathayil Aboobacker Fouzia2, Thomas Vizhalil Paul1.   

Abstract

Entities:  

Year:  2019        PMID： 32042704      PMCID： PMC6987781          DOI： 10.4103/ijem.IJEM_566_19

Source DB:  PubMed          Journal:  Indian J Endocrinol Metab        ISSN： 2230-9500


× No keyword cloud information.
  3 in total

1.  Concurrent male gynecomastia and testicular hydrocele after imatinib mesylate treatment of a gastrointestinal stromal tumor.

Authors:  Hawk Kim; Heung-Moon Chang; Min-Hee Ryu; Tae-Won Kim; Hee-Jung Sohn; So-Eun Kim; Hye-Jin Kang; Sarah Park; Jung-Shin Lee; Yoon-Koo Kang
Journal:  J Korean Med Sci       Date:  2005-06       Impact factor: 2.153

2.  Gynaecomastia in men with chronic myeloid leukaemia after imatinib.

Authors:  Carlo Gambacorti-Passerini; Lucia Tornaghi; Francesco Cavagnini; Pellegrino Rossi; Francesca Pecori-Giraldi; Luigi Mariani; Nadia Cambiaghi; Enrico Pogliani; Gianmarco Corneo; Lucio Gnessi
Journal:  Lancet       Date:  2003-06-07       Impact factor: 79.321

3.  Gynecomastia during imatinib mesylate treatment for gastrointestinal stromal tumor: a rare adverse event.

Authors:  HeLi Liu; GuoQing Liao; ZhongShu Yan
Journal:  BMC Gastroenterol       Date:  2011-11-02       Impact factor: 3.067
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.